Immunohistochemical profile of vegf, tgf-ß and pge2in human pterygium and normal conjunctiva: Experimental studyand review of the literature

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 3, 2012, Pages 607-615

  Bianchi, E ^a   Scarinci, F ^c   Grande, C ^a   Plateroti, R ^a   Plateroti, A M ^a   Fumagalli, L ^a   Capozzi, P ^d   Feher, J ^a,b   Artico, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Ophthalmic Neuroscience Program   (Italy)

^c IRCCS FONDAZIONE BIETTI   (Italy)

^d Bambino Gesii Children's Hospital IRCCS   (Italy)

Author keywords

Conjunctiva; Immunohistochemistry; Pterygium; TGF beta; VEGF

Indexed keywords

AVIDIN; PEROXIDASE; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ANTIBODY LABELING; CADAVER; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; REVIEW; STROMA CELL;

EID: 84868015527     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500307     Document Type: Review

References (30)

1. Spencer WH. Ophthalmie Pathology: An Atlas and Textbook, 3rd edn. WB Saunders Co: Philadelphia, 1985, pp 304.
2. Reese AB. Tumors of the Eye, 3rd edn. Harper & Row: New York, 1976, pp 53-55
3. Cameron ME. Histology of pterygium: an electron microscopic study. Br J Ophthalmol 1983; 67:604-8. (Pubitemid 13036819)
4. Hill JC, Maske R. Pathogenesis of pterygium. Eye 1989;3:218-26. (Pubitemid 20018565)
5. Sodhi PK, Verma L, Pandey RM, Ratan S. Comparison between the role of intraoperative mitomycin C and doxorubicin in preventing the recurrence of primary pterygium. Ophthalmic Res 2005; 37:1-6. (Pubitemid 40663226)
6. Dushku N, Reid TW. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbar epithelial basal cells. Curr Eye Res 1994; 13:473-81. (Pubitemid 24215983)
7. Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Emmett EA. Corneal changes associated with chronic UV irradiation. Arch Ophthalmol 1989; 107:1481-4. (Pubitemid 19247253)
8. Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium. Acta Histochem 1996; 98:195-201. (Pubitemid 26161915)
9. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235:442-7. (Pubitemid 17009577)
10. Tsanou E, Ioachim E, Stefaniotou M, et al. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes. Int J Clin Pract 2005; 59:1157-61. (Pubitemid 43904521)
11. Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996; 32: 2413-22.
12. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-39.
13. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246:1306-9. (Pubitemid 20066716)
14. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-5.
15. Dvorak HF. Tumors: wounds that do not heal. Similarity between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-59. (Pubitemid 17052899)
16. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992; 153: 557-62.
17. Ueta M, Matsuoka T, Yokoi N, Kinoshita S. Prostaglandin E2 suppresses polyinosinepolycytidylic acid (polyI:C)-stimulated cytokine production via prostaglandin E2 receptor (EP) 2 and 3 in human conjunctival epithelial cells. Br J Ophthalmol 2011; 95: 859-63.
18. Dushku N, Reid TW. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res 1994; 13:473-81. (Pubitemid 24215983)
19. Karukonda SR, Thompson HW, Beuerman RW, Lam DS, Wilson R, Chew SJ, Steinemann TL. Cell cycle kinetics in pterygium at three latitudes. Br J Ophthalmol 1995; 79: 313-17.
20. Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000;84:212-16. (Pubitemid 30251668)
21. Pinkerton OD, Hokama Y, Shigemura LA. Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol 1984; 98:225-8. (Pubitemid 14058281)
22. Choul Yong Park, Jong Sun Choi, Sung Jun Lee, Sang Won Hwang, Eo-jin Kim, Roy S. Chuck. Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor. Molecular Vision 2011; 17: 3468-80.
23. Luo H, Chen Z, Jin H, Zhuang M, Wang T, Su C, Lei Y, Zou J, Zhong B. Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer. J Exp Clin Cancer Res 2011; 30: 6.
24. Rizzo MT. Cyclooxygenase-2 in oncogenesis. Clin Chim Acta 2011; 412: 671-87.
25. Solomon A, Li DQ, Lee SB, Tseng SC. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest Ophthalmol Vis Sei 2000; 41:2154-63. (Pubitemid 30450987)
26. Di Girolamo N, Wakefield D, Coroneo MT. UVBmediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sei 2006; 47:2430-37. (Pubitemid 351639824)
27. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246:1306-9. (Pubitemid 20066716)
28. Senger DR, Galii SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-5.
29. Aspiotis M, Tsanou E, Gorezis S, Ioachim E, Skyrlas A, Stefaniotou M, Malamou-Mitsi V. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1. Eye 2007; 21:1095-101. (Pubitemid 47263760)
30. Fallah Tafti MR, Khosravifard K, Mohammadpour M, Hashemian MN, Kiarudi MY. Efficacy of intralesional bevacizumab injection in decreasing pterygium size. Cornea 2011; 30: 127-9.